EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Validation and Performance of the Barcelona- and ERSPC-MRI Predictive Model in an Ibero-American Population of Men Suspected of Having Prostate Cancer

Nahuel Paesano, Violeta Catalá, Juan Camean, Tomás Eduardo Olmedo, Joaquín Ignacio Gurovich, Maximiliano Ringa, Berta Miró iD, Lucas Regis, Olga Mendez, Enrique Trilla, Juan Morote

Cancers · 07.08.2026 · 18 (16) · 2541

DOI: 10.3390/cancers18162541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 07.08.2026. Verfasst von Nahuel Paesano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Uro-Radiology Unit, Clínica Creu Blanca, 08034 Barcelona, Spain. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salut Carlos III, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

External validation of predictive models is needed in new populations after their implementation.

Objective

We aimed to validate and compare the performance of the BCN-MRI PM and ERSPC-MRI PM in an Ibero-American population.

Methods

We conducted a retrospective analysis of 540 men with suspected PCa who underwent MRI and prostate biopsy in 2025. Individual csPCa risk estimates were calculated using the online calculators for the BCN-MRI PM and ERSPC-MRI PM. The reference standard outcome was the rate of avoided biopsies. Calibration, discrimination of csPCa, net benefit, and clinical utility were analyzed with R software.

Results

All participants underwent MRI and prostate biopsy. The median age was 66 years (95% CI 61–71). The overall csPCa detection rate was 55.7%. The BCN-MRI PM demonstrated good calibration, with close agreement between predicted and observed csPCa probabilities, whereas the ERSPC-MRI PM underestimated risk in the intermediate-probability range. Discrimination for csPCa was significantly better with the BCN-MRI PM (AUC, 0.807; 95% CI 0.771–0.843) than with the ERSPC-MRI PM (AUC, 0.764; 95% CI 0.724–0.803; p < 0.001). Decision curve analysis showed a greater net benefit for the BCN-MRI PM than for the ERSPC-MRI PM and the strategy of biopsying all men. Clinical utility curves demonstrated a more favorable balance between avoided biopsies and missed csPCa cases across threshold probabilities. At a sensitivity of 95%, the BCN-MRI PM achieved a specificity of 38.9% (95% CI, 32.5–45.1%) compared with 30.1% (95% CI, 24.6–35.7%) for the ERSPC-MRI PM, avoiding 21.5% and 16.3% of biopsies, respectively (p = 0.043). The performance of both models was also evaluated according to PI-RADS category and participating center.

Conclusions

In this Ibero-American cohort, the BCN-MRI PM demonstrated superior calibration and overall clinical performance compared with the ERSPC-MRI PM.

Schlagwörter

Stichwörter der Autor:innen

clinically significant prostate cancermagnetic resonance imagingpredictive model

Autor:innen und Institutionen

  • Uro-Radiology Unit, Clínica Creu Blanca, 08034 Barcelona, Spain.
  • Department of Surgical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
  • Department of Urology, Hospital Clínico Universidad de Chile, Independencia, Santiago 8380456, Chile.
  • Department of Urology, Hospital Alemán, Buenos Aires 1424, Argentina.
  • Bioinformatics and Statistical Unit, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.
  • Research Group in Urology, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.

ORCID-Profile: Berta Miró

Förderung

  • Instituto de Salut Carlos III
  • Instituto de Salud Carlos III

Zitieren

APA

Paesano, N., Catalá, V., Camean, J., Olmedo, T. E., Gurovich, J. I., Ringa, M., Miró, B., Regis, L., Mendez, O., Trilla, E., & Morote, J. (2026). Comparative Validation and Performance of the Barcelona- and ERSPC-MRI Predictive Model in an Ibero-American Population of Men Suspected of Having Prostate Cancer. Cancers, 18(16), 2541. https://doi.org/10.3390/cancers18162541

Vancouver

Paesano N, Catalá V, Camean J, Olmedo TE, Gurovich JI, Ringa M, et al. Comparative Validation and Performance of the Barcelona- and ERSPC-MRI Predictive Model in an Ibero-American Population of Men Suspected of Having Prostate Cancer. Cancers. 2026;18(16):2541. doi:10.3390/cancers18162541

BibTeX
@article{Paesano2026,
  author = {Paesano, Nahuel and Catalá, Violeta and Camean, Juan and Olmedo, Tomás Eduardo and Gurovich, Joaquín Ignacio and Ringa, Maximiliano and Miró, Berta and Regis, Lucas and Mendez, Olga and Trilla, Enrique and Morote, Juan},
  title = {Comparative Validation and Performance of the Barcelona- and ERSPC-MRI Predictive Model in an Ibero-American Population of Men Suspected of Having Prostate Cancer},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {16},
  pages = {2541},
  doi = {10.3390/cancers18162541}
}
Kostenlos starten →